Trials
3 active
3 in total
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “XNW28012 for Injection (2.4 mg/kg, administered once every 3 weeks)”In the company’s words, NCT07823049 on ClinicalTrials.gov
- Tested for
- Pancreatic Cancer, Advanced Solid Tumors, Pancreatic Carcinoma, Ovarian Cancer, Cervical Cancers, Metastatic Pancreatic Cancer
- Main trialPhase 3
- “This study was a randomized, double-blind, multicenter phase III clinical study. A total of 226 patients with metastatic pancreatic ductal carcinoma who had failed or were intolerant to two previous standard therapies were planned.Subjects will be randomized in a 2:1 ratio to either the experimental group or the control group:Experimental Group: XNW28012 for Injection (2.4 mg/kg, administered once every 3 weeks);Control group: XNW28012 mimetic for Injection (administered once every 3 weeks).Both experimental and control subjects will receive optimal supportive care, including but not limited…”In the company’s words, NCT07823049 on ClinicalTrials.gov
Other drugs for Pancreatic Cancer
- CAM2029Camurus AB · Phase 3
- Immuncell-LCGC Cell Corporation · Phase 3
- RYZ101RayzeBio, Inc. · Phase 3
- IvonescimabAkeso · Summit Therapeutics · Phase 3
- DaraxonrasibRevolution Medicines · Phase 3
- IBI343Innovent · Phase 3
Coming up3
- 31 DecPhase 1/2 trial completes · ClinicalTrials.gov
- 31 May 2027Phase 3 trial completes · ClinicalTrials.gov
- 30 Apr 2028Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 May 2027 | Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy | |
| Phase 1/2Recruiting | 31 Dec 2026 | Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments | |
| Phase 1Not yet recruiting | 30 Apr 2028 | Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026